This NDC is on FDA's drug shortage list (posted Mar 10, 2023)
Product Information
CLONAZEPAM 1 MG TABLET is a generic product labeled by Solco Healthcare US LLC, priced at $0.0245 per EA under NDC 43547040711. Its NADAC has been published 434 times since May 2, 2018.
FDA first approved this application on Jun 28, 2006. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
1 mg/1
Manufacturer
Solco Healthcare US LLCNDC
43547040711
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
CLONAZEPAMApproval Type
Generic (ANDA)
FDA Application
ANDA077856FDA Approved
6/28/2006
TE Code
AB
On Market Since
2/15/2018
Pharmacological Classes
Price Statistics
The NADAC for CLONAZEPAM 1 MG TABLET has been published 434 times since May 2, 2018, and over the history we have for it it has held within roughly two percent of its current level. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.0245 per EA |
|---|---|
| All-time high | $0.0348 (Apr 15, 2020) |
| All-time low | $0.0244 (Jul 22, 2026) |
| 52-week high | $0.0300 |
| 52-week low | $0.0244 |
| Median price | $0.0302 |
| Average price | $0.0299 |
| Largest weekly change | +23.6% (Jun 19, 2024) |
| Weeks tracked | 434 |
| Tracking since | May 2, 2018 |
Generic Alternatives
The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of CLONAZEPAM 1 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for CLONAZEPAM 1 MG TABLET, manufactured by Solco Healthcare US LLC, is $0.0245 per EA (NDC 43547040711), effective Aug 19, 2026.
How has the price of CLONAZEPAM 1 MG TABLET changed over time?
Over the history we have for it, the NADAC for CLONAZEPAM 1 MG TABLET has held within roughly two percent of its current level. It has been tracked across 434 weekly CMS publications since May 2, 2018.
What are the highest and lowest recorded NADAC prices for CLONAZEPAM 1 MG TABLET?
Since May 2, 2018, the NADAC for CLONAZEPAM 1 MG TABLET has ranged from a low of $0.0244 (Jul 22, 2026) to a high of $0.0348 (Apr 15, 2020), with a median of $0.0302 per EA.
Are there cheaper alternatives to CLONAZEPAM 1 MG TABLET?
6 manufacturers publish a NADAC-priced product with the same active ingredient and strength as CLONAZEPAM 1 MG TABLET in a comparable dosage form, but none are currently priced below it.
Who manufactures CLONAZEPAM 1 MG TABLET?
CLONAZEPAM 1 MG TABLET (NDC 43547040711) is labeled by Solco Healthcare US LLC, and CMS classifies it as a generic product.
Is CLONAZEPAM 1 MG TABLET in shortage?
Yes — NDC 43547040711 is currently listed in FDA's drug shortage database (posted Mar 10, 2023).